Recombinant Tuberculosis vaccine (Jiangsu Recbio Technology)

重组成人结核病疫苗(江苏瑞科生物)

Report date: 2025/12/11 10:27:30

Base Information

Drug NameRecombinant Tuberculosis vaccine (Jiangsu Recbio Technology)
Drug Alias NameREC-606
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A